Citizenship

Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, PMP, Conference

FOSTER CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs” or the “Company”), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced that Thomas Bock, M.D., Chief Executive Officer of Notable Labs, will participate in a fireside chat at the Citizens JMP Securities Life Sciences Conference 2024, taking place on May 13-14, 2024, in New York City.

Key Points: 
  • FOSTER CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs” or the “Company”), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced that Thomas Bock, M.D., Chief Executive Officer of Notable Labs, will participate in a fireside chat at the Citizens JMP Securities Life Sciences Conference 2024, taking place on May 13-14, 2024, in New York City.

AGS Enters Into Definitive Agreement To Be Acquired By Brightstar Capital Partners for Approximately $1.1 Billion

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, LLP, EDT, Investment, Macquarie Group, Barclays, Kirkland & Ellis, Culture, JMP, Jefferies Group, Cooley LLP, AGS, Cryptocurrency

The Company’s Board of Directors has unanimously approved, and recommended that the Company's stockholders approve, the agreement.

Key Points: 
  • The Company’s Board of Directors has unanimously approved, and recommended that the Company's stockholders approve, the agreement.
  • AGS is a global company focused on creating a diverse mix of entertaining gaming experiences for every kind of player.
  • Joining forces with Brightstar represents an exciting new chapter for AGS and our mission to provide exceptional gaming solutions for our operator partners,” said David Lopez, CEO & President of AGS.
  • Upon completion of the transaction, AGS will become a privately held company and shares of AGS common stock will no longer be listed on any public market.

CareCloud Retains Citizens JMP as its Exclusive Capital Structure Advisor

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, CareCloud

SOMERSET, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it has retained Citizens JMP as its exclusive capital structure advisor.

Key Points: 
  • SOMERSET, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it has retained Citizens JMP as its exclusive capital structure advisor.
  • The retention of Citizens JMP by the Company was prompted by its recent receipt of an unsolicited indication of interest from a third-party to acquire the Company.
  • The Company’s Board of Directors exercised its fiduciary duty to evaluate the indication of interest, which was non-binding and subject to satisfactory due diligence, and declined to accept it as proposed.
  • As the Company’s advisor, Citizens JMP will evaluate CareCloud’s capital structure and provide guidance regarding possible modifications to its Series A Preferred Stock.

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, Conference

WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14.

Key Points: 
  • WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14.
  • ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat.
  • A live webcast of the fireside chat can be accessed here and on the Company’s website under Events and Presentations .
  • The recording will be archived and available on the Company’s website for 90 days.

PDS Biotech to Participate in Upcoming May 2024 Investor Conferences

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, Biotechnology, Immune system, PDSB

PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the Company will participate in two upcoming investor conferences taking place in May 2024.

Key Points: 
  • PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the Company will participate in two upcoming investor conferences taking place in May 2024.
  • Details are as follows:
    To register for the presentation, click here .
  • Please contact your Citizens JMP representative to schedule a 1:1 meeting with PDS Biotech.
  • Fireside Chat Date and Time: Tuesday, May 21, 2024, 10:00 AM ET

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Retrieved on: 
Donnerstag, Mai 9, 2024
Citizenship, Therapy, Patient, Conference, Webcast

WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in The Citizens JMP Life Sciences Conference on May 13, 2024.

Key Points: 
  • WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in The Citizens JMP Life Sciences Conference on May 13, 2024.
  • The Aquestive management team will hold a fireside chat on May 13 at 11:30 am ET and will host investor meetings.
  • A webcast of the fireside chat will be available on the "Events and Presentation" page of the Investors section of the Company's website.
  • A replay of the webcast will be available for 30 days following the event.

Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

Retrieved on: 
Mittwoch, Mai 8, 2024
Citizenship, Clearside, Conference, Webcast, Fireside, Eye, Pharming, MBA

ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 9:30 a.m.

Key Points: 
  • ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 9:30 a.m.
  • ET in New York, NY.
  • A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations .
  • An archive of the webcast will be available for three months.

Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
Mittwoch, Mai 8, 2024
FDA, Citizenship, Research and development, Attack, Food, EOP, Research, Book, Trial of the century, Conference, Administration, Hereditary angioedema, Record, Bank statement, HAE, Growth

Joan Schmidt, J.D., Chief Legal Officer of Pharvaris, has given notice of her resignation, effective June 1, 2024.

Key Points: 
  • Joan Schmidt, J.D., Chief Legal Officer of Pharvaris, has given notice of her resignation, effective June 1, 2024.
  • R&D expenses were €18.5 million for the quarter ended March 31, 2024, compared to €13.7 million for the quarter ended March 31, 2023.
  • G&A expenses were €9.8 million for the quarter ended March 31, 2024, compared to €7.3 million for the quarter ended March 31, 2023.
  • Pharvaris is a Foreign Private Issuer and prepares and reports consolidated financial statements and financial information in accordance with IFRS as issued by the International Accounting Standards Board.

Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference

Retrieved on: 
Mittwoch, Mai 8, 2024
Citizenship, Microglia, Conference, Webcast

WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14th at 11:30 a.m. E.T.

Key Points: 
  • WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14th at 11:30 a.m. E.T.
  • To register for the live event, please click here .
  • The webcast will also be available on the Company’s website on the “Events & Presentations” page in the “Investors” section.
  • An archived webcast will be available for approximately 90 days following the presentation.

Aura Biosciences to Participate in Upcoming Investor Conferences

Retrieved on: 
Mittwoch, Mai 8, 2024
Citizenship, Cancer, Doctor of Philosophy, Conference, Webcast, Fireside chats, Flour

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:

Key Points: 
  • BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:
    The Citizens JMP Life Sciences Conference on Monday, May 13, 2024.
  • Fireside Chat at 9:00 a.m.
  • ET.
  • TD Cowen 5th Annual Oncology Innovation Summit on Wednesday, May 29, 2024.